Legal status · United States
Is NNZ-2591 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. NNZ-2591 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
- People given it
- 0
- Found nothing
- 0
Legal category
Investigational, not approved
FDA approval and compounding status, from the NNZ-2591 profile.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
NNZ-2591 in the United States at a glance
| Legal category | Investigational, not approved |
|---|---|
| FDA approval status | Investigational; in final-stage studies. The FDA gave it Fast Track and Orphan (rare disease) status |
| Studies in people | 2 of 2 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the NNZ-2591 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
NNZ-2591 is being tested in registered clinical trials (official studies in people). FDA has not approved it for sale in the United States.
- 02
The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.
What NNZ-2591 is
A pill that copies a natural breakdown product of IGF-1, from the makers of trofinetide (Daybue). Since February 2026 it has been in the first ever final-stage study for Phelan-McDermid syndrome.
NNZ-2591 is a lab-made copy of cyclic glycine-proline, a natural breakdown product of IGF-1. It is a sister drug to trofinetide, which Neuren took to approval for Rett syndrome.
How it works: It brings IGF-1 and nerve cell signals in the brain back toward normal, helping nerve cells connect in these developmental conditions.
Approval history: Investigational; in final-stage studies. The FDA gave it Fast Track and Orphan (rare disease) status
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for NNZ-2591 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
NNZ-2591 in sport and the military
Whether NNZ-2591 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up NNZ-2591 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
NNZ-2591 in other countries
Frequently asked questions
Is NNZ-2591 legal in the United States?
No. NNZ-2591 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
Can I buy NNZ-2591 in the United States?
There is no approved product to buy. In the United States, NNZ-2591 has the legal category "Investigational, not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Is NNZ-2591 FDA approved?
No. FDA status: Investigational; in final-stage studies. The FDA gave it Fast Track and Orphan (rare disease) status. Current US legal category: "Investigational, not approved". On the evidence, 1 completed human trial is cited on its profile.
Related compounds in the United States
Full research profile
How NNZ-2591 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
NNZ-2591 profileThis page is general information about the legal status of NNZ-2591 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.